Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management

JS Knight, DW Branch, TL Ortel - bmj, 2023 - bmj.com
Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease propelled by
circulating autoantibodies that recognize cell surface phospholipids and phospholipid …

[HTML][HTML] Antiphospholipid syndrome in children

MZ Avramovic, T Avcin - Best Practice & Research Clinical Rheumatology, 2024 - Elsevier
Antiphospholipid syndrome (APS) in children is a rare disease associated with significant
morbidity and mortality. In comparison with APS in adults, pediatric APS has a more severe …

Updates in diagnosis and treatment of pediatric antiphospholipid syndrome

LM Campos, PS Marra, CR Doria, SD Cordoba… - Current Rheumatology …, 2024 - Springer
Abstract Purpose of Review This review offers an overview of the most important recent
articles on pediatric APS. Recent Findings Non-thrombotic extra criteria manifestations were …

Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION)“ …

GGM Balbi, P Gaspar, H Cohen, DA Isenberg… - Seminars in Arthritis and …, 2025 - Elsevier
Objectives To gather the perspectives of APS ACTION members regarding the strengths and
limitations of Damage Index for Antiphospholipid Syndrome (DIAPS); and establish …

Recurrent thrombotic events in pediatric antiphospholipid syndrome: A systematic review and meta-analysis

A Zabeida, A Bosch, E Uleryk, L Avila - Thrombosis Research, 2024 - Elsevier
Background Pediatric antiphospholipid syndrome (APS) is one of the most common
acquired hypercoagulable states in children, yet it remains poorly characterized. Objectives …

Pediatric presentation of antiphospholipid syndrome: a review of recent literature with estimation of local prevalence

M Radin, I Cecchi, M Arbrile, D Montin… - … in Thrombosis and …, 2024 - thieme-connect.com
We aimed to investigate the epidemiology, the clinical and laboratory characteristics of the
pediatric involvement of antiphospholipid syndrome (APS), by performing a review of the …

Non-criteria antiphospholipid antibodies and calprotectin as potential biomarkers in pediatric antiphospholipid syndrome

EE Sloan, K Kmetova, SK NaveenKumar, L Kluge… - Clinical …, 2024 - Elsevier
Our study aimed to evaluate the presence, clinical associations, and potential mechanistic
roles of non-criteria antiphospholipid antibodies (aPL) and circulating calprotectin, a highly …

Case Report: A case of recurrent thrombosis in pediatric antiphospholipid syndrome associated with pediatric onset systemic lupus

L Liu, L Liu, L Zhang, P Huang, X Dang, L Shuai… - Frontiers in …, 2023 - frontiersin.org
Systemic lupus erythematosus (SLE) is an autoimmune disease with multi-system
involvement as the main manifestation, and has complex and diverse clinical features …

[HTML][HTML] Immunothrombosis: A bibliometric analysis from 2003 to 2023

M Hou, J Wu, J Li, M Zhang, H Yin, J Chen, Z **… - Medicine, 2024 - journals.lww.com
Background: Immunothrombosis is a physiological process that constitutes an intravascular
innate immune response. Abnormal immunothrombosis can lead to thrombotic disorders …

Pediatric antiphospholipid syndrome: is it the same as an adult?

V Bitsadze, J Khizroeva, A Lazarchuk… - The Journal of …, 2024 - Taylor & Francis
Importance Antiphospholipid syndrome in neonates and children is a rare, but in some
cases life-threatening condition with arterial and/or venous thrombosis and/or non …